FR7461M
(pt)
|
1968-06-19 |
1970-01-05 |
|
|
EP0014815A3
(de)
|
1978-12-20 |
1980-10-29 |
Ciba-Geigy Ag |
Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
|
FI75578C
(fi)
|
1979-07-25 |
1988-07-11 |
Ciba Geigy Ag |
Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
|
US4406889A
(en)
|
1980-02-15 |
1983-09-27 |
Ciba-Geigy Corporation |
Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
GR78246B
(pt)
|
1981-01-23 |
1984-09-26 |
Ciba Geigy Ag |
|
DE3485094D1
(de)
|
1983-01-25 |
1991-10-31 |
Ciba Geigy Ag |
Neue peptidderivate.
|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
SE448277B
(sv)
|
1985-04-12 |
1987-02-09 |
Draco Ab |
Indikeringsanordning vid en doseringsanordning for lekemedel
|
US6024964A
(en)
|
1985-06-24 |
2000-02-15 |
Hoechst Aktiengesellschaft |
Membrane anchor/active compound conjugate, its preparation and its uses
|
SE453566B
(sv)
|
1986-03-07 |
1988-02-15 |
Draco Ab |
Anordning vid pulverinhalatorer
|
US5238944A
(en)
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
US4929624A
(en)
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
DE4119856A1
(de)
|
1991-06-17 |
1992-12-24 |
Hoechst Ag |
N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen
|
ATE189124T1
(de)
|
1991-07-02 |
2000-02-15 |
Inhale Inc |
Verfahren und vorrichtung zum abgeben von medikamenten in aerosolform
|
US5268376A
(en)
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
US5266575A
(en)
|
1991-11-06 |
1993-11-30 |
Minnesota Mining And Manufacturing Company |
2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
WO1994006498A1
(en)
|
1992-09-23 |
1994-03-31 |
Fisons Plc |
Inhalation device
|
DK0665759T3
(da)
|
1992-10-19 |
1999-08-23 |
Dura Pharma Inc |
Tørpulverinhalator
|
WO1994016970A1
(en)
|
1993-01-19 |
1994-08-04 |
Glaxo Group Limited |
Device
|
US5395937A
(en)
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
EP0622375A1
(de)
|
1993-02-20 |
1994-11-02 |
Hoechst Aktiengesellschaft |
Chrysospermine, Peptidwirkstoffe aus Apiocrea chrysosperma mit pharmakologischer Wirkung, ein Verfahren zu Herstellung und Verwendung derselben
|
US6288042B1
(en)
|
1993-04-23 |
2001-09-11 |
Aronex Pharmaceuticals, Inc. |
Anti-viral guanosine-rich tetrad forming oligonucleotides
|
US6794357B1
(en)
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
KR100341341B1
(ko)
|
1993-07-15 |
2002-11-25 |
미네소타 마이닝 앤드 매뉴팩춰링 캄파니 |
이미다조[4,5-c]피리딘-4-아민
|
US5352784A
(en)
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
ATE222921T1
(de)
|
1994-01-26 |
2002-09-15 |
Novartis Erfind Verwalt Gmbh |
Modifizierte oligonukleotide
|
ATE264096T1
(de)
|
1994-03-07 |
2004-04-15 |
Nektar Therapeutics |
Verfahren und mittel zur verabreichung von insulin über die lunge
|
US6727230B1
(en)
|
1994-03-25 |
2004-04-27 |
Coley Pharmaceutical Group, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
US20030026782A1
(en)
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US5482936A
(en)
|
1995-01-12 |
1996-01-09 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-C]quinoline amines
|
WO1997025086A2
(en)
|
1996-01-03 |
1997-07-17 |
Glaxo Group Limited |
Inhalation device
|
US6294177B1
(en)
|
1996-09-11 |
2001-09-25 |
Nabi |
Staphylococcus aureus antigen-containing whole cell vaccine
|
DE19642014B4
(de)
|
1996-10-11 |
2005-08-04 |
Pactec Verpackungsmaschinen-Fabrik Theegarten Gmbh & Co. Kg |
Vorrichtung zum Verpacken kleinstückiger Artikel im Falteinschlag
|
HUP9904665A3
(en)
|
1996-10-25 |
2000-11-28 |
Minnesota Mining And Mfg Co Sa |
Immune response modifier compounds for treatment of th2 mediated and related diseases
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
US5921447A
(en)
|
1997-02-13 |
1999-07-13 |
Glaxo Wellcome Inc. |
Flow-through metered aerosol dispensing apparatus and method of use thereof
|
JP2001513776A
(ja)
|
1997-02-28 |
2001-09-04 |
ユニバーシティ オブ アイオワ リサーチ ファウンデーション |
LPS関連障害の処置における非メチル化CpGジヌクレオチドを含む核酸の使用
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
CN1268178A
(zh)
|
1997-05-06 |
2000-09-27 |
人体基因组科学有限公司 |
粪肠球菌多核苷酸和多肽
|
ATE370740T1
(de)
|
1997-05-20 |
2007-09-15 |
Ottawa Health Research Inst |
Verfahren zur herstellung von nukleinsäurekonstrukten
|
CA2291483C
(en)
|
1997-06-06 |
2012-09-18 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
US6517839B1
(en)
|
1997-07-18 |
2003-02-11 |
The Regents Of The University Of California |
Methods for inducing interleukin-12 and a type1/Th1 T-cell response
|
UA67760C2
(uk)
|
1997-12-11 |
2004-07-15 |
Міннесота Майнінг Енд Мануфакчурінг Компані |
Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
|
ES2284247T3
(es)
|
1998-04-03 |
2007-11-01 |
University Of Iowa Research Foundation |
Metodos y productos para estimular el sistema inmunitario usando oligonucleotidos y citoquinas inmunoterapeuticos.
|
JP2002514397A
(ja)
|
1998-05-14 |
2002-05-21 |
コーリー ファーマシューティカル ゲーエムベーハー |
CpGオリゴヌクレオチドを用いる造血調節の方法
|
US6110929A
(en)
|
1998-07-28 |
2000-08-29 |
3M Innovative Properties Company |
Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
|
GB9826192D0
(en)
|
1998-12-01 |
1999-01-20 |
Controlled Theraputics Scotlan |
Oral transmucosal delivery
|
GB9905538D0
(en)
|
1999-03-10 |
1999-05-05 |
Glaxo Group Ltd |
A device
|
US6977245B2
(en)
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
US6451810B1
(en)
|
1999-06-10 |
2002-09-17 |
3M Innovative Properties Company |
Amide substituted imidazoquinolines
|
US6331539B1
(en)
|
1999-06-10 |
2001-12-18 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
US6541485B1
(en)
|
1999-06-10 |
2003-04-01 |
3M Innovative Properties Company |
Urea substituted imidazoquinolines
|
US6756382B2
(en)
|
1999-06-10 |
2004-06-29 |
3M Innovative Properties Company |
Amide substituted imidazoquinolines
|
MXPA02003108A
(es)
|
1999-09-25 |
2003-10-14 |
Univ Iowa Res Found |
Acidos nucleicos inmunoestimuladores.
|
US6949520B1
(en)
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
ATE378348T1
(de)
|
2000-01-14 |
2007-11-15 |
Us Health |
Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
|
JP4443810B2
(ja)
|
2000-01-26 |
2010-03-31 |
イデラ ファーマシューティカルズ インコーポレイテッド |
ヌクレオシドの位置的修飾によるオリゴヌクレオチドCpG誘導性免疫刺激の調節
|
EP1253947A4
(en)
|
2000-01-31 |
2005-01-05 |
Univ California |
IMMUNOMODULATED POLYNUCLEOTIDES FOR THE TREATMENT OF INFECTIONS BY INTRA-CELLULAR DISEASES
|
US7585847B2
(en)
|
2000-02-03 |
2009-09-08 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for the treatment of asthma and allergy
|
US20010046967A1
(en)
|
2000-03-10 |
2001-11-29 |
Gary Van Nest |
Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide
|
US7157437B2
(en)
|
2000-03-10 |
2007-01-02 |
Dynavax Technologies Corporation |
Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences
|
US6534062B2
(en)
|
2000-03-28 |
2003-03-18 |
The Regents Of The University Of California |
Methods for increasing a cytotoxic T lymphocyte response in vivo
|
EP1278761B1
(en)
|
2000-05-01 |
2005-04-06 |
Hybridon, Inc. |
MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES
|
PT1296714E
(pt)
|
2000-06-22 |
2009-10-15 |
Coley Pharm Gmbh |
Combinação de cpg e anticorpos dirigidos contra cd19, cd20, cd22 ou cd40 para o tratamento ou prevenção do cancro
|
EP1366077B1
(en)
|
2000-09-15 |
2011-05-25 |
Coley Pharmaceutical GmbH |
PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
|
UA74852C2
(en)
|
2000-12-08 |
2006-02-15 |
3M Innovative Properties Co |
Urea-substituted imidazoquinoline ethers
|
US6677347B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamido ether substituted imidazoquinolines
|
ES2307568T3
(es)
|
2000-12-08 |
2008-12-01 |
Coley Pharmaceutical Gmbh |
Acidos nucleicos de tipo cpg y metodos de uso de los mismos.
|
US6667312B2
(en)
|
2000-12-08 |
2003-12-23 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
US20050287612A1
(en)
|
2000-12-29 |
2005-12-29 |
John Bertin |
CARD-4 molecules and uses thereof
|
US7176296B2
(en)
|
2001-04-30 |
2007-02-13 |
Idera Pharmaceuticals, Inc. |
Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
|
US7105495B2
(en)
|
2001-04-30 |
2006-09-12 |
Idera Pharmaceuticals, Inc. |
Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
|
US7785610B2
(en)
|
2001-06-21 |
2010-08-31 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same—III
|
ES2487645T3
(es)
|
2001-06-21 |
2014-08-22 |
Dynavax Technologies Corporation |
Compuestos inmunomoduladores quiméricos y métodos de uso de los mismos
|
CN1642982A
(zh)
|
2001-07-26 |
2005-07-20 |
唐诚公司 |
活化或抑制类Toll受体9的试剂
|
CN1604795B
(zh)
|
2001-08-17 |
2010-05-26 |
科勒制药股份公司 |
具有提高的活性的组合基序免疫刺激寡肽
|
WO2003027313A2
(en)
|
2001-09-24 |
2003-04-03 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE
|
WO2003094836A2
(en)
|
2001-10-12 |
2003-11-20 |
University Of Iowa Research Foundation |
Methods and products for enhancing immune responses using imidazoquinoline compounds
|
US7276489B2
(en)
|
2002-10-24 |
2007-10-02 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
|
US8466116B2
(en)
|
2001-12-20 |
2013-06-18 |
The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of CpG oligodeoxynucleotides to induce epithelial cell growth
|
KR100965026B1
(ko)
|
2002-02-13 |
2010-06-21 |
이뮤놀로지 래보러토리스 인코포레이티드 |
미생물 감염증을 치료하기 위한 조성물 및 방법
|
EP2368431A1
(en)
|
2002-04-04 |
2011-09-28 |
Coley Pharmaceutical GmbH |
Immunostimulatory G,U-containing oligoribonucleotides
|
CA2483012C
(en)
|
2002-04-22 |
2011-05-24 |
Bioniche Life Sciences Inc. |
Oligonucleotide compositions and their use for the modulation of immune responses
|
KR100456681B1
(ko)
|
2002-05-22 |
2004-11-10 |
주식회사 대웅 |
박테리아의 염색체 dna 파쇄물과 비독성리포폴리사카라이드를 포함하는 면역강화 및 조절 조성물
|
CA2388049A1
(en)
|
2002-05-30 |
2003-11-30 |
Immunotech S.A. |
Immunostimulatory oligonucleotides and uses thereof
|
AU2003243409A1
(en)
|
2002-06-05 |
2003-12-22 |
Coley Pharmaceutical Group, Inc. |
Method for treating autoimmune or inflammatory diseases with combinations of inhibitory oligonucleotides and small molecule antagonists of immunostimulatory cpg nucleic acids
|
US7605138B2
(en)
|
2002-07-03 |
2009-10-20 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7569553B2
(en)
|
2002-07-03 |
2009-08-04 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US20040053880A1
(en)
|
2002-07-03 |
2004-03-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7807803B2
(en)
|
2002-07-03 |
2010-10-05 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7576066B2
(en)
|
2002-07-03 |
2009-08-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
NZ538628A
(en)
|
2002-08-12 |
2008-06-30 |
Dynavax Tech Corp |
Immunomodulatory compositions, methods of making, and methods of use thereof
|
DK1545597T3
(da)
|
2002-08-15 |
2011-01-31 |
3M Innovative Properties Co |
Immunstimulerende sammensætninger og fremgangsmåde til stimulering af en immunrespons
|
AR040996A1
(es)
|
2002-08-19 |
2005-04-27 |
Coley Pharm Group Inc |
Acidos nucleicos inmunoestimuladores
|
WO2004024919A1
(en)
|
2002-09-13 |
2004-03-25 |
Replicor, Inc. |
Non-sequence complementary antiviral oligonucleotides
|
MXPA05004588A
(es)
|
2002-10-29 |
2005-12-14 |
Coley Pharmaceutical Group Ltd |
Metodos y productos relacionados con el tratamiento y prevencion de infeccion de virus de hepatitis c.
|
WO2004041183A2
(en)
|
2002-11-01 |
2004-05-21 |
The Regents Of The University Of California |
Methods of treating pulmonary fibrotic disorders
|
US7491395B2
(en)
|
2002-11-20 |
2009-02-17 |
Bestewil Holding B.V. |
Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination
|
EP2353614A1
(en)
|
2002-11-21 |
2011-08-10 |
Bayhill Therapeutics, Inc. |
Methods and immune modulatory nucleic acid compositions for preventing and treating disease
|
AU2003300919A1
(en)
|
2002-12-11 |
2004-06-30 |
Coley Pharmaceutical Gmbh |
5' cpg nucleic acids and methods of use
|
AU2003301052A1
(en)
|
2002-12-20 |
2004-07-22 |
3M Innovative Properties Company |
Aryl / hetaryl substituted imidazoquinolines
|
US8158768B2
(en)
|
2002-12-23 |
2012-04-17 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
AU2003300184B8
(en)
|
2002-12-30 |
2009-12-03 |
3M Innovative Properties Company |
Immunostimulatory combinations
|
US20040259790A1
(en)
*
|
2003-01-30 |
2004-12-23 |
Bali Pulendran |
Methods for identifying and administering agents that bias the immune response via dendritic cells
|
DK1599164T3
(en)
|
2003-02-03 |
2015-04-27 |
Cerebus Biolog Inc |
METHODS OF TREATMENT, PREVENTION AND DETECTION OF HELICOBACTER INFECTION
|
WO2004071459A2
(en)
|
2003-02-13 |
2004-08-26 |
3M Innovative Properties Company |
Methods and compositions related to irm compounds and toll-like receptor 8
|
JP2006519020A
(ja)
|
2003-02-27 |
2006-08-24 |
スリーエム イノベイティブ プロパティズ カンパニー |
Tlr介在生物活性の選択的調節
|
CA2521050A1
(en)
|
2003-04-02 |
2004-10-14 |
Coley Pharmaceutical Group, Ltd. |
Immunostimulatory nucleic acid oil-in-water formulations and related methods of use
|
KR20060028675A
(ko)
|
2003-05-12 |
2006-03-31 |
아피맥스, 인크. |
신규한 폴리 (에틸렌 글리콜) 개질 화합물 및 그의 용도
|
US20050032829A1
(en)
|
2003-06-06 |
2005-02-10 |
3M Innovative Properties Company |
Process for imidazo[4,5-c]pyridin-4-amines
|
MXPA05013658A
(es)
|
2003-06-11 |
2006-03-02 |
Hybridon Inc |
Oligonucleotidos inmunomoduladores estabilizados.
|
JP2007524615A
(ja)
|
2003-06-20 |
2007-08-30 |
コーリー ファーマシューティカル ゲーエムベーハー |
低分子トール様レセプター(tlr)アンタゴニスト
|
US20050013812A1
(en)
|
2003-07-14 |
2005-01-20 |
Dow Steven W. |
Vaccines using pattern recognition receptor-ligand:lipid complexes
|
MXPA06000619A
(es)
|
2003-07-15 |
2006-04-11 |
Hybridon Inc |
Estimulacion sinergistica del sistema inmune usando oligonucleotidos inmunoestimuladores y/o compuestos inmunomeros en conjunto con citocinas y/o agentes quimioterapeuticos o terapia de radiacion.
|
ATE502949T1
(de)
|
2003-07-25 |
2011-04-15 |
Changchun Huapu Biotechnology Co Ltd |
Das künstliche cpg single strand deoxidation- oligonukleotid und dessen antivirale anwendungen
|
MXPA06001674A
(es)
|
2003-08-12 |
2006-05-12 |
3M Innovative Properties Co |
Compuestos que contienen imidazo hidroxilamina-sustituidos.
|
EP1660026A4
(en)
|
2003-09-05 |
2008-07-16 |
3M Innovative Properties Co |
TREATMENT FOR CD5 + B CELL LYMPHOMA
|
US20050163764A1
(en)
|
2003-09-22 |
2005-07-28 |
Yale University |
Treatment with agonists of toll-like receptors
|
EP1663316A2
(en)
|
2003-09-25 |
2006-06-07 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid lipophilic conjugates
|
US7544697B2
(en)
|
2003-10-03 |
2009-06-09 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and analogs thereof
|
US20090075980A1
(en)
|
2003-10-03 |
2009-03-19 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and Analogs Thereof
|
EP1689433B1
(en)
|
2003-10-22 |
2010-06-30 |
ID Biomedical Corporation of Quebec |
Compositions and methods for activating innate and allergic immunity
|
US20050215501A1
(en)
|
2003-10-24 |
2005-09-29 |
Coley Pharmaceutical Group, Inc. |
Methods and products for enhancing epitope spreading
|
US7202234B2
(en)
|
2003-10-24 |
2007-04-10 |
Eisai Co., Ltd. |
Compounds and methods for treating Toll-like receptor 2-related diseases and conditions
|
UA88457C2
(ru)
|
2003-10-30 |
2009-10-26 |
Коли Фармасьютикал Гмбх |
Иммуностимулирующая нуклеиновая кислота с улучшенной иммуностимулирующей эффективностью
|
US20050239733A1
(en)
|
2003-10-31 |
2005-10-27 |
Coley Pharmaceutical Gmbh |
Sequence requirements for inhibitory oligonucleotides
|
US20050100983A1
(en)
|
2003-11-06 |
2005-05-12 |
Coley Pharmaceutical Gmbh |
Cell-free methods for identifying compounds that affect toll-like receptor 9 (TLR9) signaling
|
CN1906192A
(zh)
|
2003-11-14 |
2007-01-31 |
3M创新有限公司 |
羟胺取代的咪唑环化合物
|
EP1685129A4
(en)
|
2003-11-14 |
2008-10-22 |
3M Innovative Properties Co |
OXIMSUBSTITUTED IMIDAZORING CONNECTIONS
|
US7713535B2
(en)
|
2003-12-08 |
2010-05-11 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties by small oligonucleotide-based compounds
|
EP1697511A4
(en)
|
2003-12-11 |
2007-11-21 |
Vaxdesign Corp |
IMMUNOTHERAPY COMPOSITIONS, METHODS FOR PREPARING AND USING THE SAME
|
US20050175630A1
(en)
*
|
2003-12-23 |
2005-08-11 |
Eyal Raz |
Immunogenic compositions and methods of use thereof
|
EP1550458A1
(en)
*
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergistic liposomal adjuvants
|
US20050239735A1
(en)
|
2003-12-30 |
2005-10-27 |
3M Innovative Properties Company |
Enhancement of immune responses
|
KR100558851B1
(ko)
|
2004-01-08 |
2006-03-10 |
학교법인연세대학교 |
면역조절능력이 증가된 CpG 올리고데옥시뉴클레오티드변형체
|
AU2005230938A1
(en)
|
2004-02-19 |
2005-10-20 |
Coley Pharmaceutical Gmbh |
Immunostimulatory viral RNA oligonucleotides
|
CA2555105A1
(en)
|
2004-02-20 |
2005-09-09 |
Hybridon, Inc. |
Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
|
JP2007531746A
(ja)
|
2004-04-02 |
2007-11-08 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
Il−10応答を誘導するための免疫活性化核酸
|
JP2008501807A
(ja)
|
2004-06-08 |
2008-01-24 |
コーリー ファーマシューティカル ゲーエムベーハー |
抗原ならびに免疫活性化アゴニストおよび免疫活性化アンタゴニストのための担体基本骨格としての無塩基オリゴヌクレオチド
|
US7498425B2
(en)
|
2004-06-15 |
2009-03-03 |
Idera Pharmaceuticals, Inc. |
Immunostimulatory oligonucleotide multimers
|
EE200700003A
(et)
|
2004-06-15 |
2007-06-15 |
Idera Pharmaceuticals, Inc. |
Immunostimuleeriv oligonukleotiid ning selle kasutamine
|
US7425548B2
(en)
|
2004-07-09 |
2008-09-16 |
Variety Chidren's Hospital |
Materials and methods for immune system stimulation
|
EP2484374A1
(en)
|
2004-07-18 |
2012-08-08 |
CSL Limited |
Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses
|
WO2006134423A2
(en)
|
2004-07-18 |
2006-12-21 |
Coley Pharmaceutical Group, Ltd. |
Methods and compositions for inducing innate immune responses
|
WO2006029223A2
(en)
|
2004-09-08 |
2006-03-16 |
Children's Medical Center Corporation |
Method for stimulating the immune response of newborns
|
MY159370A
(en)
|
2004-10-20 |
2016-12-30 |
Coley Pharm Group Inc |
Semi-soft-class immunostimulatory oligonucleotides
|
NZ555886A
(en)
|
2004-12-01 |
2009-12-24 |
Celgene Corp |
Methods and compositions using immunomodulatory compounds for the treatment of immunodeficiency disorders
|
US9809824B2
(en)
|
2004-12-13 |
2017-11-07 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
CpG oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
|
AU2005322898B2
(en)
|
2004-12-30 |
2011-11-24 |
3M Innovative Properties Company |
Chiral fused (1,2)imidazo(4,5-c) ring compounds
|
US20080119508A1
(en)
|
2004-12-30 |
2008-05-22 |
3M Innovative Properties Company |
Multi-Route Administration Of Immune Response Modifier Compounds
|
JP2008530022A
(ja)
|
2005-02-04 |
2008-08-07 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
免疫反応調節物質を含む水性ゲル処方物
|
CA2597324C
(en)
|
2005-02-09 |
2015-06-30 |
Coley Pharmaceutical Group, Inc. |
Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines
|
AU2006213746A1
(en)
|
2005-02-11 |
2006-08-17 |
Coley Pharmaceutical Group, Inc. |
Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods
|
AU2006216822A1
(en)
*
|
2005-02-22 |
2006-08-31 |
Daniel Rachmilewitz |
Methods of treating gastrointestinal inflammation
|
WO2006091567A2
(en)
|
2005-02-23 |
2006-08-31 |
Coley Pharmaceutical Group, Inc. |
Hydroxyalkyl substituted imidazoquinoline compounds and methods
|
WO2006091647A2
(en)
|
2005-02-23 |
2006-08-31 |
Coley Pharmaceutical Group, Inc. |
Method of preferentially inducing the biosynthesis of interferon
|
US8178677B2
(en)
|
2005-02-23 |
2012-05-15 |
3M Innovative Properties Company |
Hydroxyalkyl substituted imidazoquinolines
|
EP1851220A2
(en)
|
2005-02-23 |
2007-11-07 |
3M Innovative Properties Company |
Hydroxyalkyl substituted imidazonaphthyridines
|
JP2008531018A
(ja)
|
2005-02-24 |
2008-08-14 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
免疫刺激性オリゴヌクレオチド
|
US8138173B2
(en)
|
2005-04-01 |
2012-03-20 |
3M Innovative Properties Company |
Pyrazolo[3,4-C]quinolines, pyrazolo[3,4-C]naphthyridines, analogs thereof, and methods
|
US7943636B2
(en)
|
2005-04-01 |
2011-05-17 |
3M Innovative Properties Company |
1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
|
JP2008535832A
(ja)
|
2005-04-01 |
2008-09-04 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
ピラゾロピリジン−1,4−ジアミン、およびそのアナログ
|
BRPI0610449A2
(pt)
|
2005-04-08 |
2012-01-10 |
Coley Pharm Group Inc |
métodos para tratar asma exarcebada por doença infecciosa
|
AR056327A1
(es)
|
2005-04-25 |
2007-10-03 |
Genelabs Tech Inc |
Compuestos de nucleosidos para el tratamiento de infecciones virales
|
US20060241076A1
(en)
|
2005-04-26 |
2006-10-26 |
Coley Pharmaceutical Gmbh |
Modified oligoribonucleotide analogs with enhanced immunostimulatory activity
|
JP2008546658A
(ja)
|
2005-06-16 |
2008-12-25 |
ウニヴァシテイト ゲント |
ヘリコバクターに対する免疫化のためのワクチン
|
WO2006138478A2
(en)
|
2005-06-17 |
2006-12-28 |
The Trustees Of The University Of Pennylvania |
Stimulation of toll-like receptors on t cells
|
EA200800268A1
(ru)
|
2005-07-07 |
2008-06-30 |
Коли Фармасьютикал Груп, Инк. |
КОМБИНИРОВАННАЯ ТЕРАПИЯ АНТИТЕЛОМ ПРОТИВ CTLA-4 И СОДЕРЖАЩИМ CpG-МОТИВ СИНТЕТИЧЕСКИМ ОЛИГОДЕЗОКСИНУКЛЕОТИДОМ ДЛЯ ЛЕЧЕНИЯ ЗЛОКАЧЕСТВЕННОЙ ОПУХОЛИ
|
JP5481068B2
(ja)
|
2005-08-31 |
2014-04-23 |
アメリカ合衆国 |
CpGオリゴデオキシヌクレオチドによって誘発される免疫応答を変化させる方法
|
ZA200803029B
(en)
|
2005-09-09 |
2009-02-25 |
Coley Pharm Group Inc |
Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
|
WO2007031322A1
(en)
|
2005-09-14 |
2007-03-22 |
Gunther Hartmann |
Compositions comprising immunostimulatory rna oligonucleotides and methods for producing said rna oligonucleotides
|
KR20080048067A
(ko)
|
2005-09-16 |
2008-05-30 |
콜리 파마슈티칼 게엠베하 |
포스포디에스테르 주쇄를 갖는 면역자극성 단일가닥리보핵산
|
CN101321868A
(zh)
|
2005-09-16 |
2008-12-10 |
科利制药公司 |
通过核苷酸修饰调节短干扰核糖核酸(siRNA)的免疫刺激特性
|
US8426375B2
(en)
|
2005-10-12 |
2013-04-23 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
|
WO2007047396A2
(en)
|
2005-10-12 |
2007-04-26 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
|
US8399423B2
(en)
|
2005-10-12 |
2013-03-19 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
|
CA2630738C
(en)
|
2005-11-25 |
2013-09-03 |
Coley Pharmaceutical Gmbh |
Immunostimulatory oligoribonucleotides
|
WO2007075626A2
(en)
|
2005-12-20 |
2007-07-05 |
Idera Pharmaceuticals, Inc. |
Immunostimulatory activity of palindromic immune modulatory oligonucleotides (imo tm) contiaining different lengths of palindromic segments
|
JP2009520502A
(ja)
|
2005-12-20 |
2009-05-28 |
イデラ ファーマシューティカルズ インコーポレイテッド |
Cgジヌクレオチド修飾物を含有するトール様受容体の新規な合成アゴニスト
|
EP1991678B2
(en)
|
2006-02-15 |
2020-07-15 |
Rechtsanwalt Thomas Beck |
Compositions and methods for oligonucleotide formulations
|
US8106173B2
(en)
|
2006-04-07 |
2012-01-31 |
Idera Pharmaceuticals, Inc. |
Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8
|
US20090176696A1
(en)
|
2006-04-18 |
2009-07-09 |
The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth |
Methods And Compositions For Modulating An Immune Response
|
WO2008008432A2
(en)
|
2006-07-12 |
2008-01-17 |
Coley Pharmaceutical Group, Inc. |
Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
|
US20080170996A1
(en)
|
2006-07-28 |
2008-07-17 |
The Board Of Regents Of The University Of Texas System |
Compositions and Methods for Stimulation of Lung Innate Immunity
|
US20080124366A1
(en)
|
2006-08-06 |
2008-05-29 |
Ohlfest John R |
Methods and Compositions for Treating Tumors
|
US8377898B2
(en)
|
2006-10-12 |
2013-02-19 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
|
US20080241139A1
(en)
|
2006-10-31 |
2008-10-02 |
Regents Of The University Of Colorado |
Adjuvant combinations comprising a microbial tlr agonist, a cd40 or 4-1bb agonist, and optionally an antigen and the use thereof for inducing a synergistic enhancement in cellular immunity
|
US20090142362A1
(en)
|
2006-11-06 |
2009-06-04 |
Avant Immunotherapeutics, Inc. |
Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (CETP)
|
JP2010510223A
(ja)
*
|
2006-11-15 |
2010-04-02 |
サ ブリガム アンド ウィメンズ ホスピタル インコーポレーティッド |
Tim−3調節物質の治療的使用
|
WO2008073959A2
(en)
|
2006-12-12 |
2008-06-19 |
Idera Pharmaceuticals, Inc. |
Synthetic agonists of tlr9
|
CA2699190A1
(en)
|
2007-04-19 |
2009-10-30 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders
|
WO2009015107A1
(en)
|
2007-07-20 |
2009-01-29 |
Yeda Research And Development Co. Ltd. |
Modulation of toll-like receptors for controlling neurogenesis
|
CN102864151B
(zh)
|
2007-08-01 |
2015-07-08 |
艾德拉药物股份有限公司 |
Tlr9的新型合成性激动剂
|
EP2591787A1
(en)
|
2007-08-13 |
2013-05-15 |
Pfizer Inc |
Combination motif immune stimulatory oligonucleotides with improved activity
|
AU2008286735A1
(en)
|
2007-08-15 |
2009-02-19 |
Idera Pharmaceuticals, Inc. |
Toll like receptor modulators
|
WO2009088401A2
(en)
|
2007-09-24 |
2009-07-16 |
Government Of The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Immunostimulatory combinations of tlr ligands and methods of use
|
US9872867B2
(en)
|
2008-06-06 |
2018-01-23 |
Tanya Kuritz |
Methods and compositions for modulation of innate immunity
|
MX2011010050A
(es)
*
|
2009-03-25 |
2011-12-14 |
Univ Texas |
Composiciones para estimulación de resistencia inmune innata de mamiferos a patógenos.
|